ANURASAnupam Rasayan India Limited Forensic Risk Analysis

Specialty Chemicals
Risk ClassWatch
Market Cap₹13,924 Cr
Primary DriverBalance Sheet Stress
Flagium AI Risk Score
Early signs of stress detected. Not yet widespread, but initial deterioration is visible.
31 / 100
+16 QoQ
Early Deterioration
Sentinel Insight

Financial profile remains stable for now. Weakness is detected in balance sheet stress. This suggests a building risk profile. Risk is increasing at a faster pace.

78.0th %ile (Sector)Accel: +2 Qtrs
Updated2026-06-02
Market View
₹1,324.9▼0.25%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Balance Sheet Stress
+15.8 pts
Earnings Quality
+15.0 pts
Final Composite Risk31 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 10 → 31 over 13 quarters.

Expected Direction
🚨 Escalate
Primary Deterioration Drivers
  • Margin Compression
  • Inventory Stress
  • Industrial Margin Stress
What to Watch Next Quarter
  • Operating profit margins
  • Operating cash flow
  • Inventory turnover

Active Risk Objects (11)

CriticalHigh
Industrial Margin Stress
📉 Trend DeteriorationAnnualActive for 6 Years
More Detail
Impact Weight12/15
MomentumPersistent
Last SignalQ4 FY2026
ANURAS: EBITDA margin compressed by 8.0 bps YoY and Raw material costs consumed an additional 4.4% of revenue YoY.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2025
Aggressive Capex (85.2%) amidst slow revenue growth (-25.2%).

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Margin Compression
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ4 FY2026
Operating margin declined by 8.7 bps YoY for two consecutive quarters.

"Margins are in freefall. Operating costs are growing significantly faster than revenue."

Negative FCF Streak
⚖️ Governance SignalsAnnualActive for 1 Years
More Detail
Impact Weight6/15
MomentumAccelerating
Last SignalFY2026
ANURAS: Negative Free Cash Flow for last 3 consecutive years.

"High capital expenditure and low OCF are draining cash. Debt levels may rise sharply."

Cash Conversion Deficit
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight6/15
MomentumPersistent
Last SignalFY2026
ANURAS: OCF below Net Profit in 2/3 recent years.

"Cash conversion is dangerously low. Operational cash flow is significantly trailing reported PAT."

Inventory Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight15/15
MomentumDecaying
Last SignalQ2 FY2025
Inventory growth (25.8%) significantly outpaced revenue growth (-25.2%).

"Inventory overhang is clearing. Stock levels are normalizing as sales momentum returns."

Profit Collapse
📊 Earnings QualityQuarterlyActive for 2 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ1 FY2025
ANURAS: Net Profit collapsed by 76.6% from FY2024 Q1 to FY2025 Q1.

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 4 Years
More Detail
Impact Weight10/15
MomentumPersistent
Last SignalQ4 FY2026
Working capital expansion detected: Receivable days increased by 3.4%.

"Early signs of working capital expansion. Receivable or inventory days are creeping up."

Operating Leverage Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight10/15
MomentumAccelerating
Last SignalQ4 FY2026
Expenses are consistently growing faster than revenues, creating operational pressure.

"Debt levels are creeping up. Monitor for signs of excessive borrowing for non-core activities."

Low Interest Coverage
💧 Liquidity & CoverageQuarterlyActive for 4 Qtrs
More Detail
Impact Weight8/15
MomentumPersistent
Last SignalQ4 FY2026
ANURAS: Low Interest Coverage Ratio of 2.34x in FY2026 Q4 (Threshold: 2.5x).

"Earnings buffer for interest payments is narrowing. Monitor for margin pressure."

Revenue-Debt Divergence
🏛️ Solvency & LeverageAnnualActive for 2 Years
More Detail
Impact Weight6/15
MomentumDecaying
Last SignalFY2025
ANURAS: Revenue fell 3.8% while Debt rose 29.2% in 2025 vs 2024.

"Debt servicing metrics have improved recently. The company is actively deleveraging."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)9.0810.68✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+35.0+46.0📈 CRITICAL
Forensic Benchmark Context: Specialty Chemicals (n=51 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹1,324.9(-0.25%)
1M Divergence-3.67%
1 Week-3.31%
1 Month-1.41%
6 Months+5.87%
1 Year+31.92%
2 Year+74.01%
3 Year+18.73%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The risk profile is Early Signals and currently deteriorating. Recent structural triggers in balance sheet stress suggest a building pressure on the underlying framework. Material forensic traces are visible in core structural metrics, indicating a progressive erosion of structural stability. Strategic vigilance is advised as structural decay is accelerating.

ANURAS • MARKET STRUCTURE

Stage 2 — Advancing

The company is in a growth phase. Institutional sentiment is highly positive, supported by strong fundamentals and sustained risk reduction.

Stage Transition Prob.95%
Trend QualityDeveloping
Phase Progression
Phase Progression Score65%
Readiness LabelModerate (Transition Potential Building)
Probability of Advancing95%
CoinTree Momentum
Composite Z-Score-0.1167σ
Weakening momentum trend
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#1227 of 2716
Top 45.18% in momentum strength
Timeframe Sparklines
1W-3.3%
1M-1.4%
6M+5.9%
Weinstein Indicators
150 DMA₹1,265.45
200 DMA₹1,225.95
150 DMA Slope+2.8769%Rising
Relative Strength+11.05%Leading
Relative Turnover (RTR)1.2783
ParticipationHealthy

PEER COMPARISON

Ranked comparison against sector peers

This company shows higher risk compared to the Sector Mean (20).
AARTIINDAarti Industries Limited
20 Risk
Sector %ile46th
Delta-5
Active Flags24
Accel+0
Balance Sheet Stress

Watch

ANURASAnupam Rasayan India Limited
31 Risk
Sector %ile78th
Delta+16
Active Flags11
Accel+2
Balance Sheet Stress

Watch

ACIArchean Chemical Industries Limited
35 Risk
Sector %ile84th
Delta+20
Active Flags22
Accel+1
Earnings Quality

Watch

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
00th %ile
VS Sector Median (8.5)
Balance Sheet Stress
2.120.8th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
10100th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Operating Leverage Stress

2026

Margin Compression

2026

Working Capital Expansion

2026

Industrial Margin Stress

2026

Operating Leverage Stress

2026

Industrial Margin Stress

2026

Industrial Margin Stress

2026

Industrial Margin Stress

2026

Negative FCF Streak

2026

Cash Conversion Deficit

2025

Industrial Margin Stress

2025

Inventory Stress

2025

Working Capital Expansion

2025

Capex Efficiency Stress

2025

Revenue-Debt Divergence

2025

Cash Conversion Deficit

2024

Industrial Margin Stress

2024

Working Capital Expansion

2024

Inventory Stress

2024

Working Capital Expansion

2024

Capex Efficiency Stress

2024

Cash Conversion Deficit

2024

Revenue-Debt Divergence

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY20262,3842223341,815
FY20251,448160-301,318
FY20241,505167591,020
FY20231,610217292788